Member Info for Energyshares

Euston we have problem.....

That last sentence is pure gold once machines installed or using machines already installed a new pipeline of targets for Bams & affimers

BAMSTM is quite versatile and can be utilized to monitor any protein (or a panel of proteins) of interest.”

With age of company ,I think we could of negotiated 40% to 50% royalty until Bruker came along and both would be diluted by Bruker.

Adeptrix 1 year old seed of $5 million from 3 sources.

National Science Foundation

U.S. Department of Health and Human
U.S. Department of Health and Human Services

North Shore InnoVentures

The BAMS™ assay platform is a disruptive technology, because it provides a simple workflow for targeted proteomics and will enable many more scientists to ask deeper questions of their biological assays,” said Dr. Jeffrey C. Silva, Director of Product Development at Adeptrix Corporation. “The assay technology couples the specificity of affinity capture with the speed and sensitivity of mass spectrometry detection to enable screening of ONE to THOUSANDS of proteins in a single experiment. BAMSTM is quite versatile and can be utilized to monitor any protein (or a panel of proteins) of interest.”

1st May RNS

Adeptrix and Avacta are already in discussion with large-scale manufacturing partners to rapidly deploy this new high throughput test.
Further commercial details are not being disclosed but Avacta will receive a royalty on the sales of BAMS test kits by Adeptrix.

At this time Adeptrix had 1 employee.
So I think Avacta with supplying the Affimers, they would of had to do a lot of the development work and I know they did the clinical validation as it states this on Adeptrix website.

So my point is,if Avacta team done a lot of the development we should be looking at a minimum 50% Royalty.
Adeptrix now have 5 employees
But the LinkedIn now states 2-10 employees.

What does every one think 50% royalty more or less

Bloody hell its like One Flew Over the Cuckoo's Nest on here tonight.
Let’s get back to research Gents & Ladies

GxP compliance is new software developed by Bruker for faster FDA and other regulatory compliance.

Let’s hope they are using this on BAMS

https://bit.ly/3iRNTl8

Wonder what the exciting product launch is tomorrow
for Bruker.....

One hell of a spike hopefully money flowing over here

We Shall Not Be Moved.

Just a word to the idiots who keep trying to disrupt this BB.

A lot of us have done research for months,day after day and built up life changing positions with Avacta.

It would only be a fool who would sell before Big Al sends out the Golden RNS.

M&M’s try every day but everyone is holding firm.

So half a dozen sad little Rats spreading lies & gloom each day haven’t got a chance of any one selling this side of £10.

So keep doing your best ....

Only at home test being evaluated at the moment. BOOOOOOOOOMMMMM!

Testing technologies of Government interest
The Government is supporting innovation for improved testing technologies, both laboratory-based and more recently for tests that can be carried out at scale and at the point-of-care. The Government is also exploring whether other samples can be used, such as saliva rather than nose and throat swabs. Several companies mentioned in a recent Government statement are working on this:
Avacta: a laboratory test using mass spectrometry on nose and throat swabs and on saliva samples. The company is also developing an antigen saliva test.
Chronomics: a laboratory PCR test that can be carried out on saliva samples.
MAP Science: a laboratory test using mass spectrometry on saliva samples.
Oxford Nanoimaging: is developing a portable technology that uses microscopy to detect whole virus in samples including saliva.
The Government has invested in point-of-care testing technologies; research is underway to see how well they work in testing programmes in a range of settings:

Rick Body on Twitter

Great stuff #NHS - now let's see if we can get *100* sites open for the @falcon_study. Every hospital should be working to get new tests into practice for the benefit of *us all*!

“Every hospital”, eh.... sounds an awful lot like BAMS but #AVCT

We’re doing our utmost to assist with your incredible contribution to #COVID19 testing. There’s now a national initiative for mass spec - watch this space but we’re working extremely hard to help you & all the other inspirational companies working in this field!

Best paragraph in this release:

Government plans for mass screening using tests
On 9 September, the Prime Minister announced the Government’s intention to implement a mass screening programme to identify people who are not infected. The proposed purpose of such a programme would be to enable people who are not infected to have fewer restrictions on their daily activities. This approach is also called universal testing or population-based screening. It would operate by offering regular testing using technologies that give rapid results. The emphasis in the announcement was that this would be contingent on the availability of rapid tests that could produce a result in 20–90 minutes, using saliva or nose and throat swabs. Such an undertaking would require a vast expansion of diagnostic capacity involving new technologies for which the evidence base is incomplete but developing. While the technologies described above may contribute to this increased testing capacity, they all share similar constraints to laboratory testing because they need special equipment, trained operators and logistics for delivering samples and returning results.
The technology best suited to mass screening is antigen tests because they are cheap and can be made in large quantities. The trade-off for using this cheap and rapid technology is that their lower sensitivity means that they are less accurate at identifying people who do have an infection. This could result in many people with an infection being told that they do not. The World Health Organization recommends that a person who has symptoms but tests negative with an antigen test, should be offered a follow up confirmatory RT-PCR test.

Every RNS Big Al mentioning mass testing.
Then on results RSN he changes is wording to :

Avacta Diagnostics
· Collaboration with Cytiva (formerly GE Healthcare Life Sciences) to develop a rapid test for the COVID-19 coronavirus antigen for mass population screening.

Government release

Government plans for mass screening
Moonshot.
As Jurgen Klopp would say.
BOOOOOOOOMMMM.

Testing station at Liverpool
John Lennon Airport
Everyone has been told to Quarantine....

Imagine all the People........

Can’t buy at moment 1k top up

Just seeing if anyone else picked up on this.
Company called Readybuy plc started off selling Chinese ready meals in 2003

Then became Avacta in 2006 reverse takeover...
So everyone get ready to buy

Chinese ready meals To World dominance.

Both these post taken down from yesterday’s twitter ?????

The 10p is just a nominal value and what is shown in the company balance sheet. This is an historical value not a market value and won't change over time. The company may even have sold them for more than the 10p at times if it has had additional share issues.

Chuckle brothers MFM & Global trying to keep this thread going with AW new account skin flint
Just ignore them

Chuckle brothers are back